Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Comparative Research Needs New Approach To Answer Real-Life Questions

Executive Summary

To get the most out of the new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions so that it can answer real-world questions, two former CMS officials said at a recent forum at the American Enterprise Institute
Advertisement

Related Content

Three Amendments On Comparative Effectiveness Research Fail During Finance Committee Markup
CER Draft Definition Raises No Red Flags, But More Clarity Sought
CER Draft Definition Raises No Red Flags, But More Clarity Sought
Drug Safety Should Focus On “Maximizing Benefit,” Not Just “Minimizing Risk” – FDA’s Goodman
AHRQ Is Comparatively Better Off With Steve Phurrough’s Move From CMS To Agency’s Outcomes Office
Comparative Effectiveness Language Clarified In Compromise Stimulus Bill
FDA Post-Market Safety Efforts Won’t Be Impacted By Sentinel In Near Term
Lilly Zyprexa, Symbyax Labeling Strengthened
Hypertension Labeling Should Say Classes Are All Effective, But Unequally So

Topics

Advertisement
UsernamePublicRestriction

Register

PS050716

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel